Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03329313
PHASE2

Effects of Variation of Sodium Dialysate in ICU

Sponsor: University Hospital, Montpellier

View on ClinicalTrials.gov

Summary

Intermittent hemodialysis/diafiltration is a current renal replacement therapy (RRT) institued for ICU patients with AKI. For a better clinical tolerance, iinternational guidelines advise to use cold dialysate, increase duration session, decrease blood and dialysate flows, and increase level of sodium dialysate concentration (≥ 145mmol/l). Indeed, the use of a Na concentration dialysate \> 145 mmol/l improves intradialytic hemodynamic tolerance but it may also induce fluid overload by the transfert of sodium from the dialysate compartment to the blood. Yet, fluid overload has been strongly associated with mortality in critically ills. The investigators hypothesized that the use of a level in sodium dialysate at 140 mmol/l with slow low efficiency daily dialysis-filtration (SLEDD-f) will permit a fair intradialytic hemodynamic tolerance without the adverse effect of intradiaclytic Na loading from the dialysate. Two randomized groups of ICU AKI patients treated by SLEDD-f will be compared in terms of intradialytic hemodynamic tolerance and overload accordong to 140 or 145 mmol/l of Na in the dialysate

Official title: Effects of Variation of Sodium Dialysate in ICU Acute Kiney Injury

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

158

Start Date

2018-04-19

Completion Date

2026-12-19

Last Updated

2025-09-30

Healthy Volunteers

No

Interventions

DRUG

Lowering sodium concentration dialysate

Concentration of sodium in dialysate at 140 mmol/l

DRUG

Highing sodium concentration dialysate

Concentration of sodium in dialysate at 145 mmol/l

Locations (1)

Uhmontpellier

Montpellier, Montpellier, France